1.17 USD
▲+0.01+4.46%
盘后 1.10 -1.79%
2026-08-03
市值
$159.18M
市盈率
—
EPS
-0.68
股息率
—
52 周区间
1.00 – 3.06
成交量
1.32M
Beta
0.97
目标价
6.33
52W 低 1.0052W 高 3.06
价格走势
公司简介
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Ph...